title: Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease.
abstract: Insulin-degrading enzyme (IDE; insulysin; EC 3.4.24.56) is a 110-kDa neutral metallopeptidase that can degrade a number of peptides including beta-amyloid. The gene encoding IDE is located on chromosome 10 close to a region of linkage for late-onset Alzheimer's disease (LOAD) and thus is a functional and positional candidate for this disorder. We analysed all of the coding exons, untranslated regions and 1000 bp of 5'-flanking sequence of IDE by using denaturing high-performance liquid chromatography and sequencing. We detected eight single nucleotide polymorphisms (SNPs), three in the 5' flanking sequence and five in the coding sequence, of which three were found at lower than 5% frequency. None of them changed the amino acid sequence. We genotyped the five SNPs with allele frequencies of more than 5% in 133 Caucasian LOAD cases and 135 controls collected in the UK and 95 cases and 117 controls collected at the Mayo Clinic, Rochester, USA. Two of the SNPs were analysed in a further independent case-control sample (Washington University, St. Louis: 86 cases, 94 controls). No significant association was found with any individual SNP in any of the samples or with any haplotypes. Analysis of the marker D10S583, which maps 36 kb upstream of IDE, also failed to show association in 134 cases and 111 matched controls from the UK ( P=0.63). Strong linkage disequilibrium was detected between the five SNPs that spanned the whole of the 120-kb genomic region of IDE and one major and a number of minor haplotypes were detected in the populations studied. We conclude that IDE does not make a substantial contribution to the aetiology of LOAD and therefore cannot account for the linkage between LOAD and 10q.
authors.affiliation: Department of Psychological Medicine, University of Wales College of Medicine, Cardiff CF14 4XN, Wales, UK.
authors.forename: R
authors.initials: R
authors.lastname: Abraham
authors.forename: A
authors.initials: A
authors.lastname: Myers
authors.forename: F
authors.initials: F
authors.lastname: Wavrant-DeVrieze
authors.forename: M L
authors.initials: ML
authors.lastname: Hamshere
authors.forename: H V
authors.initials: HV
authors.lastname: Thomas
authors.forename: H
authors.initials: H
authors.lastname: Marshall
authors.forename: D
authors.initials: D
authors.lastname: Compton
authors.forename: G
authors.initials: G
authors.lastname: Spurlock
authors.forename: D
authors.initials: D
authors.lastname: Turic
authors.forename: B
authors.initials: B
authors.lastname: Hoogendoorn
authors.forename: J M
authors.initials: JM
authors.lastname: Kwon
authors.forename: R C
authors.initials: RC
authors.lastname: Petersen
authors.forename: E
authors.initials: E
authors.lastname: Tangalos
authors.forename: J
authors.initials: J
authors.lastname: Norton
authors.forename: J C
authors.initials: JC
authors.lastname: Morris
authors.forename: R
authors.initials: R
authors.lastname: Bullock
authors.forename: D
authors.initials: D
authors.lastname: Liolitsa
authors.forename: S
authors.initials: S
authors.lastname: Lovestone
authors.forename: J
authors.initials: J
authors.lastname: Hardy
authors.forename: A
authors.initials: A
authors.lastname: Goate
authors.forename: M
authors.initials: M
authors.lastname: O'Donovan
authors.forename: J
authors.initials: J
authors.lastname: Williams
authors.forename: M J
authors.initials: MJ
authors.lastname: Owen
authors.forename: L
authors.initials: L
authors.lastname: Jones
mesh_terms: D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D000544:Alzheimer Disease / Q000209:etiology / Q000235:genetics*; D016022:Case-Control Studies; D014644:Genetic Variation; D006801:Humans; D007339:Insulysin / Q000235:genetics*; D015810:Linkage Disequilibrium; D020641:Polymorphism, Single Nucleotide; D044465:White People
chemical_list: D007339:Insulysin